Physiological CSTC Circuit

Physiological Cognitive Control
OXIPASSIVE®
Supporting adjunctive neuro-redox homeostasis to target Cortico-Striato-Thalamo-Cortical (CSTC) pathway hyperactivity.

Primary Biological Targets

1 - DISEASE BIOLOGY
Physiological CSTC signaling coordinates behavioral inhibition and cognitive flexibility. In patients with OCD, chronic hyperactive glutamatergic signaling triggers a progressive neurobiological dysregulation cascade.

Physiological Cognitive Control

⚠ Loss of Cognitive Control
L-Glutamine Dysregulation Pathway
↑ Glutamatergic Dysregulation
↓ Endogenous Glutathione
↓ Adaptive Neuroplasticity
Persistent Obsession-Compulsion Loop
2 - PATIENT SELECTION




Adjunctive Neuro-Redox Support
3 - NEURO-REDOX INTERVENTION IN CSTC CIRCUIT DYSFUNCTION
Support of physiological glutamate regulation
Reduction of CSTC glutamatergic dysregulation
Reduction of oxidative neurobiological stress
Support of endogenous neuro-redox homeostasis
Supports neural circuit recovery (CSTC function)
Supports physiological NMDA receptor function
Supports adaptive neuroplasticity
Supports cognitive flexibility
Reinforces physiological CSTC signaling
Supports neuronal resilience
Persistent CSTC Hyperactivity

Glutamatergic Dysregulation

Obsessions

Compulsions

Oxipassive® (NAC + Glycine)

Adaptive Neuroplasticity

Resilience

Cognitive Flexibility

Support of OCD Management
4 - CLINICAL POSITIONING

Adjunctive Neuro-Redox Platform integrated with standard OCD management.
5 - CLINICAL EVIDENCE DASHBOARD
Evidence Timeline

Emerging evidence suggests that Neuro-Redox modulation may also contribute to improvement of oxidative stress associated anxiety symptoms
Human Neuro Clinical TrialPMID: 37366885







GlyNAC Synthesis Trial